Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcus Biosciences (RCUS) Receivables - Net (2017 - 2018)

Historic Receivables - Net for Arcus Biosciences (RCUS) over the last 2 years, with Q4 2018 value amounting to $100000.0.

  • Arcus Biosciences' Receivables - Net rose 30000.0% to $100000.0 in Q4 2018 from the same period last year, while for Dec 2018 it was $100000.0, marking a year-over-year increase of 30000.0%. This contributed to the annual value of $100000.0 for FY2018, which is 30000.0% up from last year.
  • Per Arcus Biosciences' latest filing, its Receivables - Net stood at $100000.0 for Q4 2018, which was up 30000.0% from $100000.0 recorded in Q3 2018.
  • Arcus Biosciences' Receivables - Net's 5-year high stood at $200000.0 during Q2 2018, with a 5-year trough of $25000.0 in Q4 2017.